Standout Papers

Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in... 2012 2026 2016 2021 364
  1. Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema (2012)
    Peter A. Campochiaro, David M. Brown et al. Ophthalmology

Immediate Impact

70 standout
Sub-graph 1 of 22

Citing Papers

Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications
2025 Standout
Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
2025 Standout
1 intermediate paper

Works of Sanford Chen being referenced

Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy
2023
Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
2017

Author Peers

Author Last Decade Papers Cites
Sanford Chen 665 535 130 12 737
Teiko Yamamoto 691 556 143 33 803
Kimberley Delaunay 518 335 181 19 664
Eduardo Dib 468 420 166 24 581
Todd E. Schneiderman 359 280 137 18 717
Claudia Del Turco 652 438 176 23 761
Laura Sararols 547 311 167 22 609
Fumitaka Hirose 519 335 98 16 605
M.F. White 744 440 163 23 844
Marianna Berton 585 491 98 13 694
A W de Kater 654 339 213 15 807

All Works

Loading papers...

Rankless by CCL
2026